What Is an Investigational New Animal Drug (INAD)?
A Regulatory Pathway for Veterinary Drug Development
Veterinary medicinal products require rigorous testing to ensure that they are safe and effective for use in animals. In the United States, the development of new animal drugs is governed by the U.S. Food and Drug Administration (FDA) under the Center for Veterinary Medicine (CVM).
Staying on top of regulatory standards is a must in pharmaceuticals, biotech, and medical devices. When quality issues pop up, companies turn to Corrective Action and Preventive Action better known as CAPA. It’s not just a checkbox, either. CAPA forms the foundation of quality management systems, and regulators everywhere expect to see it in action.
Clarification on the Use of the Sister File Procedure-EDQM
The current EDQM policy PA/PH/CEP (09) 141, 2R, “Guidance on applications for “sister files”, has guided the sister file procedure for CEPs for many years. Experience gathered over time indicates that there may be discrepancies in the understanding of the procedure and the EDQM has noted that certain CEP applications are being submitted under the sister file procedure even though their characteristics would more appropriately classify them as new applications.
| Issue | Publication date | Correction date | Implementation date |
| 12.1 | 07/2025 | 31/08/2025 | 01/01/2026 |
| 12.2 | 10/2025 | 30/11/2025 | 01/04/2026 |
| 12.3 | 01/2026 | 28/02/2026 | 01/07/2026 |
| 13.1 | 04/2026 | 31/05/2026 | 01/01/2027 |
| 13.2 | 07/2026 | 31/08/2026 | 01/04/2027 |
What Is an Investigational Device Exemption (IDE)?
Enabling Clinical Trials for Medical Devices in the U.S.
If you intend to sell a medical device in the United States, it is necessary to prove it is safe and operates as intended. Before doctors can test a new device on people, the company behind it usually needs something called an Investigational Device Exemption, or IDE, from the FDA.
